AbbVie Partnering Day
Redwood City, CA
AbbVie has the expertise of a proven pharmaceutical leader and the focus and passion of a biotech. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe. AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories, Inc.
AbbVie partnerships are dedicated to two important outcomes: developing innovative new medicines and delivering a remarkable impact on peoples’ lives. AbbVie takes a highly strategic approach to developing these partnerships with a goal to create long-term mutually beneficial relationships. A passion for translating science into effective medicine and a shared vision for a successful outcome are important foundations for AbbVie partnerships.
This AbbVie Partnering Day is focused on a core set of therapeutic areas where the company has proven expertise and where AbbVie believes it can have an even greater impact on the disease and how it is managed.
- Henry Gosebruch
Executive Vice President, Chief Strategy Officer
- Scott Brun
Vice President, AbbVie Ventures
- Jay Stamatis
Vice President, Business Development & Acquisitions
- Anna Maroney
Vice President, Alliance Management
- Erik von Borcke
- Kevin Lynch
Vice President, Scientific Assessment
- Tom Hudson
Vice President, Oncology, Discovery, Early Development
- Anil Singhal
Vice President, Oncology, Early Development, Redwood City Site Head
AbbVie Partnering Day
March 28, 2017
9:00 am – 3:15 pm
3:30 pm – 5:00 pm
5:00 pm – 7:00 pm
Pullman San Francisco Bay
Parking available on-site
Application is required for one-on-one meetings. Only companies reviewed and approved will be scheduled for one-on-one partnering meeting. Application review is on a rolling basis, so we suggest applying early due to a limited number of available appointments.
The AbbVie Plenary Session followed by a Networking Reception is open to the general public. If you are interested in attending, please register below. Attendance to the Plenary Session does not guarantee a private one-on-one meeting with the AbbVie Team. For a private meeting, please submit the application above. Only companies reviewed and approved will be scheduled for a one-on-one partnering meeting.
Due to high demand, the Plenary/Reception is now restricted to employees of bioscience companies only.
|Attire:||Business attire suggested|
- Early registration is highly advised as space is limited and there will be no on-site registration
- Pre-registered attendees will receive an immediate receipt/confirmation after submission
- Please print this receipt/confirmation and bring it with you to receive your conference credentials
- Photo ID (driver’s license or passport) will be required at check-in
- All sales are final
Please mail your event-related questions to: email@example.com or you can contact us via phone: 650-871-3257.
Is your company a member? Click here to check.